scholarly journals Resistência à terapia endócrina no câncer de mama – Relato de caso / Resistance to endocrine therapy in breast cancer - Case report

2021 ◽  
Vol 4 (6) ◽  
pp. 24338-24344
Author(s):  
Luisa Weffort Vicente ◽  
Letícia Mayumi Gayardo Arai ◽  
Julia Maria Somensi Mafacioli ◽  
Ricardo Abrahim Sobrinho ◽  
Maria Cecilia Roncato Araujo Lima ◽  
...  

2020 ◽  
Vol 6 (12) ◽  
pp. 98902-98918
Author(s):  
Luiz Augusto Debona ◽  
Harry Francisco Monteiro de Lima ◽  
Taina Maria da Silva Perdigão ◽  
Flávio Lúcio Vasconcelos




Author(s):  
Inês Morais Rodrigues ◽  
Fernando Igreja ◽  
Isabel Riscado ◽  
Rosa Madureira ◽  
Ana Nobre Pinto


2014 ◽  
Vol 19 ◽  
Author(s):  
Doulira Louati ◽  
Khaled Trigui ◽  
Donia Abid ◽  
Salma Kammoun ◽  
Manel Dermech ◽  
...  


2013 ◽  
Vol 37 (4) ◽  
pp. 746-749 ◽  
Author(s):  
Elisa Francone ◽  
Marco J. Nathan ◽  
Federica Murelli ◽  
Maria Santina Bruno ◽  
Enrico Traverso ◽  
...  


Breast Care ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. 424-426 ◽  
Author(s):  
Arpine Gevorgyan ◽  
Giacomo Bregni ◽  
Giulia Galli ◽  
Elisa Zanardi ◽  
Filippo de Braud ◽  
...  

Background: Neuroendocrine carcinoma is an uncommon histology for breast cancer. Case Report: Our patient underwent right quadrantectomy for a neuroendocrine carcinoma in 1984 and had a bone relapse 30 years later. After thorough pathological and immunohistochemical analysis the diagnosis was confirmed and HER2 amplification was observed. Here we discuss the management, rationale and results of HER2-targeted therapy in advanced neuroendocrine breast carcinoma.



2020 ◽  
Vol 18 (2) ◽  
pp. 21-25
Author(s):  
Samya Jalal Wrmzyar ◽  


2019 ◽  
Vol 130 ◽  
pp. 267-270
Author(s):  
Yoshifumi Tao ◽  
Kenji Yagi ◽  
Hirotake Nishimura ◽  
Keijirou Hara ◽  
Shunji Matsubara ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document